Table of Content

1 INTRODUCTION (Page No. - 38)
    1.1 STUDY OBJECTIVES
    1.2 MARKET DEFINITION
    1.3 STUDY SCOPE
           1.3.1 MARKETS COVERED
                    FIGURE 1 NUTRACEUTICAL INGREDIENTS MARKET SNAPSHOT
           1.3.2 GEOGRAPHIC SEGMENTATION
                    FIGURE 2 NUTRACEUTICAL INGREDIENTS MARKET, BY REGION
    1.4 INCLUSIONS & EXCLUSIONS
    1.5 YEARS CONSIDERED
    1.6 CURRENCY CONSIDERED
           TABLE 1 US DOLLAR EXCHANGE RATES CONSIDERED, 2013–2018
    1.7 UNIT CONSIDERED
    1.8 STAKEHOLDERS
    1.9 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY (Page No. - 44)
    2.1 RESEARCH DATA
           FIGURE 3 NUTRACEUTICAL INGREDIENTS: RESEARCH DESIGN
           2.1.1 SECONDARY DATA
                    2.1.1.1 Key data from secondary sources
           2.1.2 PRIMARY DATA
                    2.1.2.1 Key industry insights
                    2.1.2.2 Breakdown of primary interviews
                               FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
    2.2 MARKET SIZE ESTIMATION
           2.2.1 BOTTOM-UP
                    FIGURE 5 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH
           2.2.2 TOP-DOWN
                    FIGURE 6 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
           2.2.3 SUPPLY-SIDE
                    FIGURE 7 DATA TRIANGULATION: SUPPLY-SIDE
           2.2.4 DEMAND-SIDE
                    FIGURE 8 DATA TRIANGULATION: DEMAND-SIDE
    2.3 DATA TRIANGULATION
           FIGURE 9 DATA TRIANGULATION
    2.4 RESEARCH ASSUMPTIONS & LIMITATIONS
           2.4.1 ASSUMPTIONS
    2.5 RESEARCH LIMITATIONS & ASSOCIATED RISKS

3 EXECUTIVE SUMMARY (Page No. - 55)
    TABLE 2 NUTRACEUTICAL INGREDIENTS MARKET SNAPSHOT, 2022 VS. 2027
    FIGURE 10 NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2022 VS. 2027 (USD BILLION)
    FIGURE 11 NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2022 VS. 2027 (USD BILLION)
    FIGURE 12 NUTRACEUTICAL INGREDIENTS MARKET, BY FORM, 2022 VS. 2027 (USD BILLION)
    FIGURE 13 NUTRACEUTICAL INGREDIENTS MARKET, BY REGION

4 PREMIUM INSIGHTS (Page No. - 59)
    4.1 ATTRACTIVE OPPORTUNITIES IN NUTRACEUTICAL INGREDIENTS MARKET
           FIGURE 14 INCREASED CONSUMPTION OF FORTIFIED FOODS DUE TO GROWING HEALTH CONSCIOUSNESS AMONG CONSUMERS
    4.2 ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY KEY TYPE AND COUNTRY
           FIGURE 15 INDIA AND PROBIOTICS ACCOUNTED FOR LARGEST SHARES, BY COUNTRY AND TYPE, RESPECTIVELY
    4.3 NUTRACEUTICAL INGREDIENTS MARKET: REGIONAL SUBMARKETS
           FIGURE 16 JAPAN TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD
    4.4 NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE AND REGION
           FIGURE 17 ASIA PACIFIC TO DOMINATE NUTRACEUTICAL INGREDIENTS MARKET ACROSS ALL TYPES
    4.5 NUTRACEUTICAL INGREDIENTS MARKET, BY FORM
           FIGURE 18 DRY SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
    4.6 NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION
           FIGURE 19 DIETARY SUPPLEMENTS SEGMENT TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD

5 MARKET OVERVIEW (Page No. - 63)
    5.1 INTRODUCTION
    5.2 MACROECONOMIC INDICATORS
           5.2.1 GLOBAL POPULATION WITNESSING HIGH PREVALENCE OF OBESITY
           5.2.2 KEY FACTS
                    5.2.2.1 Aging population becoming more aware of benefits of nutraceuticals
                               FIGURE 20 US POPULATION AGED 65 AND OLDER, 2000–2060 (MILLION)
                               FIGURE 21 AGING POPULATION IN JAPAN, 2014–2018
    5.3 MARKET DYNAMICS
           FIGURE 22 NUTRACEUTICAL INGREDIENTS: MARKET DYNAMICS
           5.3.1 DRIVERS
                    5.3.1.1 Growing demand for fortified food due to increased health consciousness among consumers
                               FIGURE 23 CONSUMERS' PERCEPTION REGARDING WHAT TO CONSUME OR AVOID
                    5.3.1.2 Increase in incidences of chronic diseases
                               FIGURE 24 PERCENTAGE OF US POPULATION WITH MULTIPLE CHRONIC ILLNESSES, 2017
                               FIGURE 25 CHRONIC DISEASES MOST PREVALENT WORLDWIDE AMONGST ALL AGES, 2019
                               FIGURE 26 NUMBER OF AMERICANS WITH CHRONIC CONDITIONS
                    5.3.1.3 Mandates on food fortification by government organizations
                               TABLE 3 PREVALENCE OF THREE MAJOR MICRONUTRIENT DEFICIENCIES, BY REGION
                               TABLE 4 WIDELY USED FORTIFIED FOODS
                               FIGURE 27 NUMBER OF COUNTRIES WITH MANDATORY OR VOLUNTARY FOOD FORTIFICATION, 2021
           5.3.2 RESTRAINTS
                    5.3.2.1 Higher costs of fortified products dissuade large-scale usage and adoption
           5.3.3 OPPORTUNITIES
                    5.3.3.1 Innovations in nutraceutical ingredients industry
                    5.3.3.2 Consumer awareness of micronutrient deficiencies
                               TABLE 5 FOODS TO BOOST IMMUNE SYSTEM
                               TABLE 6 MICRONUTRIENTS DEFICIENCY CONDITIONS AND THEIR WORLDWIDE PREVALENCE
           5.3.4 CHALLENGES
                    5.3.4.1 Consumer skepticism associated with nutraceutical products

6 INDUSTRY TRENDS (Page No. - 80)
    6.1 INTRODUCTION
    6.2 VALUE CHAIN ANALYSIS
           FIGURE 28 VALUE CHAIN: NUTRACEUTICAL INGREDIENTS MARKET
           6.2.1 SOURCING OF RAW MATERIALS
           6.2.2 MANUFACTURING
           6.2.3 DISTRIBUTION, MARKETING, AND SALES
    6.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
           FIGURE 29 REVENUE SHIFT FOR NUTRACEUTICAL INGREDIENTS MARKET
    6.4 TECHNOLOGY ANALYSIS
           6.4.1 FOOD MICROENCAPSULATION
                    6.4.1.1 Encapsulation of omega-3 to mask the odor
           6.4.2 INNOVATIVE AND DISRUPTIVE TECH
                    6.4.2.1 Robotics leading to innovations in market
                    6.4.2.2 3D printing to uplift dietary supplements market
                    6.4.2.3 Hologram Sciences—platform for personalized nutrition and advice
    6.5 PRICING ANALYSIS
           FIGURE 30 PRICING ANALYSIS, 2017–2022 (USD/KG)
    6.6 PATENT ANALYSIS
           FIGURE 31 PATENTS GRANTED FOR NUTRACEUTICAL INGREDIENTS MARKET, 2011–2021
           FIGURE 32 REGIONAL ANALYSIS OF PATENTS GRANTED FOR NUTRACEUTICAL INGREDIENTS MARKET, 2011–2021
           TABLE 7 KEY PATENTS PERTAINING NUTRACEUTICAL INGREDIENTS MARKET, 2021
    6.7 MARKET MAP
           6.7.1 UPSTREAM
                    6.7.1.1 Ingredient Manufacturers
                    6.7.1.2 Technology Providers
                    6.7.1.3 Start-ups/Emerging Companies
           6.7.2 DOWNSTREAM
                    6.7.2.1 Regulatory Bodies
                    6.7.2.2 End Users
                               FIGURE 33 NUTRACEUTICALS INGREDIENTS MARKET MAP
                               TABLE 8 NUTRACEUTICAL INGREDIENTS MARKET: ECOSYSTEM
    6.8 TRADE SCENARIO
           FIGURE 34 VITAMINS: IMPORT VALUE, BY KEY COUNTRY, 2017–2021 (USD THOUSAND)
           TABLE 9 IMPORT DATA OF VITAMINS FOR KEY COUNTRIES, 2021 (VALUE)
           FIGURE 35 VITAMINS: EXPORT VALUE, BY KEY COUNTRY, 2017–2021 (USD THOUSAND)
           TABLE 10 EXPORT DATA ON VITAMINS FOR KEY COUNTRIES, 2021 (VALUE)
           FIGURE 36 AMINO ACIDS: IMPORT VALUE, BY KEY COUNTRY, 2017–2021 (USD THOUSAND)
           TABLE 11 IMPORT DATA ON AMINO ACIDS FOR KEY COUNTRIES, 2021 (VALUE)
           FIGURE 37 AMINO ACIDS: EXPORT VALUE, BY KEY COUNTRY, 2017–2021 (USD THOUSAND)
           TABLE 12 EXPORT DATA ON AMINO ACIDS FOR KEY COUNTRIES, 2021 (VALUE)
    6.9 KEY CONFERENCES & EVENTS IN 2022–2023
           TABLE 13 NUTRACEUTICAL INGREDIENTS MARKET: DETAILED LIST OF CONFERENCES & EVENTS, 2022–2023
    6.10 TARIFF AND REGULATORY LANDSCAPE
           6.10.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                    TABLE 14 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                    TABLE 15 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                    TABLE 16 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                    TABLE 17 SOUTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                    TABLE 18 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
           6.10.2 REGULATORY FRAMEWORK
                    6.10.2.1 Organizations/Regulations governing nutraceutical ingredients market
                               TABLE 19 DEFINITIONS & REGULATIONS FOR NUTRACEUTICAL INGREDIENTS WORLDWIDE
                    6.10.2.2 North America
                               6.10.2.2.1 Canada
                               6.10.2.2.2 US
                               6.10.2.2.3 Mexico
                    6.10.2.3 European Union (EU)
                    6.10.2.4 Asia Pacific
                               6.10.2.4.1 Japan
                               6.10.2.4.2 China
                               6.10.2.4.3 India
                               6.10.2.4.4 Australia & New Zealand
                    6.10.2.5 Rest of the World (RoW)
                               6.10.2.5.1 Israel
                               6.10.2.5.2 Brazil
                    6.10.2.6 Probiotics
                               6.10.2.6.1 Introduction
                               6.10.2.6.2 National/International bodies for safety standards and regulations
                               TABLE 20 DEFINITIONS & REGULATIONS FOR NUTRACEUTICALS WORLDWIDE
                               6.10.2.6.3 Codex Alimentarius Commission (CAC)
                               6.10.2.6.4 North America: Regulatory environment analysis
                               6.10.2.6.5 Europe: Regulatory environment analysis
                               6.10.2.6.6 Asia Pacific: Regulatory environment analysis
                               6.10.2.6.7 South America: Regulatory environment analysis
                    6.10.2.7 Prebiotics
                               6.10.2.7.1 Introduction
                               6.10.2.7.2 Asia Pacific
                               TABLE 21 SCHEDULE – XI OF FOOD SAFETY AND STANDARDS REGULATIONS FOR LIST OF APPROVED PREBIOTIC INGREDIENTS, 2015
                               6.10.2.7.3 North America
                               TABLE 22 LIST OF ACCEPTED DIETARY FIBERS BY CANADIAN REGULATORY AUTHORITIES & THEIR SOURCES
                               6.10.2.7.4 European Union
    6.11 PORTER'S FIVE FORCES ANALYSIS
                    TABLE 23 NUTRACEUTICAL INGREDIENTS MARKET: PORTER'S FIVE FORCES ANALYSIS
           6.11.1 DEGREE OF COMPETITION
           6.11.2 BARGAINING POWER OF SUPPLIERS
           6.11.3 BARGAINING POWER OF BUYERS
           6.11.4 THREAT OF SUBSTITUTES
           6.11.5 THREAT OF NEW ENTRANTS
    6.12 KEY STAKEHOLDERS AND BUYING CRITERIA
           6.12.1 KEY STAKEHOLDERS IN BUYING PROCESS
                    FIGURE 38 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TYPES
                    TABLE 24 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TYPES (%)
           6.12.2 BUYING CRITERIA
                    TABLE 25 KEY CRITERIA FOR SELECTING SUPPLIER/VENDOR
                    FIGURE 39 KEY CRITERIA FOR SELECTING SUPPLIER/VENDOR
    6.13 CASE STUDY ANALYSIS
           6.13.1 FRUNUTTA STARTED OFFERING EASY-TO-USE AND EFFICIENT-TO-TAKE VITAMIN AND MINERAL PILLS THAT DISSOLVE INSTANTLY
           6.13.2 MINDRIGHT’S BARS HELP COMBAT MENTAL HEALTH ISSUES

7 NUTRACEUTICAL INGREDIENTS MARKET, BY HEALTH BENEFITS (Page No. - 119)
    7.1 INTRODUCTION
    7.2 COGNITIVE HEALTH
    7.3 GUT HEALTH
    7.4 HEART HEALTH
    7.5 BONE HEALTH
           TABLE 26 BONE-BUILDING NUTRIENTS & THEIR THERAPEUTIC RANGE
    7.6 IMMUNITY
    7.7 NUTRITION
    7.8 WEIGHT MANAGEMENT
    7.9 OTHERS

8 NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE (Page No. - 124)
    8.1 INTRODUCTION
           FIGURE 40 NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2022 VS. 2027 (BY VALUE)
           TABLE 27 NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017–2021 (USD MILLION)
           TABLE 28 NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2022–2027 (USD MILLION)
           TABLE 29 NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017–2021 (KT)
           TABLE 30 NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2022–2027 (KT)
    8.2 PROBIOTIC
           8.2.1 HIGH DEMAND FOR SCIENTIFICALLY PROVEN HEALTH FOODS AND DIETARY SUPPLEMENTS
                    TABLE 31 PROBIOTICS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2017–2021 (USD MILLION)
                    TABLE 32 PROBIOTICS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2027 (USD MILLION)
                    TABLE 33 PROBIOTICS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2017–2021 (KT)
                    TABLE 34 PROBIOTICS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2027 (KT)
    8.3 PROTEINS & AMINO ACIDS
           8.3.1 IMPORTANT INGREDIENTS IN FOOD AND FEED INDUSTRIES
                    TABLE 35 PROTEINS & AMINO ACIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2017–2021 (USD MILLION)
                    TABLE 36 PROTEINS & AMINO ACIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2027 (USD MILLION)
                    TABLE 37 PROTEINS & AMINO ACIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2017–2021 (KT)
                    TABLE 38 PROTEINS & AMINO ACIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2027 (KT)
    8.4 PHYTOCHEMICALS & PLANT EXTRACTS
           8.4.1 GROWING DEMAND FOR ORGANIC FOOD PRODUCTS AND INGREDIENTS
                    TABLE 39 SPECIFIC PHYTOCHEMICALS AND THEIR POTENTIAL BENEFITS
                    TABLE 40 PHYTOCHEMICALS & PLANT EXTRACTS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2017–2021 (USD MILLION)
                    TABLE 41 PHYTOCHEMICALS & PLANT EXTRACTS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2027 (USD MILLION)
                    TABLE 42 PHYTOCHEMICALS & PLANT EXTRACTS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2017–2021 (KT)
                    TABLE 43 PHYTOCHEMICALS & PLANT EXTRACTS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2027 (KT)
    8.5 FIBERS & SPECIALTY CARBOHYDRATES
           8.5.1 ADDED TO FUNCTIONAL FOOD & BEVERAGES MORE FREQUENTLY
                    TABLE 44 FIBERS & SPECIALTY CARBOHYDRATES: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2017–2021 (USD MILLION)
                    TABLE 45 FIBERS & SPECIALTY CARBOHYDRATES: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2027 (USD MILLION)
                    TABLE 46 FIBERS & SPECIALTY CARBOHYDRATES: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2017–2021 (KT)
                    TABLE 47 FIBERS & SPECIALTY CARBOHYDRATES: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2027 (KT)
    8.6 OMEGA-3 FATTY ACIDS
           8.6.1 INCREASED USE OF OMEGA-3 TO ENHANCE HEART AND BRAIN HEALTH
                    TABLE 48 OMEGA-3 FATTY ACIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2017–2021 (USD MILLION)
                    TABLE 49 OMEGA-3 FATTY ACIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2027 (USD MILLION)
                    TABLE 50 OMEGA-3 FATTY ACIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2017–2021 (KT)
                    TABLE 51 OMEGA-3 FATTY ACIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2027 (KT)
    8.7 VITAMINS
           8.7.1 AWARENESS, WIDE ACCEPTANCE, AND EASY AVAILABILITY DRIVE DEMAND
                    TABLE 52 VITAMINS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2017–2021 (USD MILLION)
                    TABLE 53 VITAMINS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2027 (USD MILLION)
                    TABLE 54 VITAMINS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2017–2021 (KT)
                    TABLE 55 VITAMINS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2027 (KT)
    8.8 PREBIOTICS
           8.8.1 USED AS TEXTURE ENHANCEMENT AND SWEETENING AGENTS
                    TABLE 56 PREBIOTICS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2017–2021 (USD MILLION)
                    TABLE 57 PREBIOTICS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2027 (USD MILLION)
                    TABLE 58 PREBIOTICS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2017–2021 (KT)
                    TABLE 59 PREBIOTICS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2027 (KT)
    8.9 CAROTENOIDS
           8.9.1 GROWING FOOD ADDITIVES AND PERSONAL CARE INDUSTRIES TO PROPEL DEMAND
                    TABLE 60 SOURCES OF CAROTENOIDS IN FRUIT AND VEGETABLES AND THEIR MEDICINAL PROPERTIES
                    TABLE 61 CAROTENOIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2017–2021 (USD MILLION)
                    TABLE 62 CAROTENOIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2027 (USD MILLION)
                    TABLE 63 CAROTENOIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2017–2021 (KT)
                    TABLE 64 CAROTENOIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2027 (KT)
    8.10 MINERALS
           8.10.1 SEVERAL HEALTH ADVANTAGES ASSOCIATED WITH MINERALS
                    TABLE 65 MACROMINERALS & THEIR FUNCTIONS
                    TABLE 66 MICROMINERALS & THEIR FUNCTIONS
                    TABLE 67 MINERALS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2017–2021 (USD MILLION)
                    TABLE 68 MINERALS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2027 (USD MILLION)
                    TABLE 69 MINERALS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2017–2021 (KT)
                    TABLE 70 MINERALS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2027 (KT)
    8.11 OTHER TYPES
                    TABLE 71 OTHER TYPES: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2017–2021 (USD MILLION)
                    TABLE 72 OTHER TYPES: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2027 (USD MILLION)
                    TABLE 73 OTHER TYPES: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2017–2021 (KT)
                    TABLE 74 OTHER TYPES: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2027 (KT)

9 NUTRACEUTICAL INGREDIENTS MARKET, BY FORM (Page No. - 155)
    9.1 INTRODUCTION
           FIGURE 41 NUTRACEUTICAL INGREDIENTS MARKET, BY FORM, 2022 VS. 2027 (BY VALUE)
           TABLE 75 NUTRACEUTICAL INGREDIENTS MARKET, BY FORM, 2017–2021 (USD MILLION)
           TABLE 76 NUTRACEUTICAL INGREDIENTS MARKET, BY FORM, 2022–2027 (USD MILLION)
    9.2 DRY
           9.2.1 BETTER STABILITY AND EASE OF HANDLING
                    TABLE 77 DRY: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2017–2021 (USD MILLION)
                    TABLE 78 DRY: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2027 (USD MILLION)
    9.3 LIQUID
           9.3.1 LIMITED APPLICATIONS COMPARED TO DRY FORM
                    TABLE 79 LIQUID: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2017–2021 (USD MILLION)
                    TABLE 80 LIQUID: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2027 (USD MILLION)

10 NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION (Page No. - 160)
     10.1 INTRODUCTION
               FIGURE 42 NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2022 VS. 2027 (VALUE)
               TABLE 81 NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2017–2021 (USD MILLION)
               TABLE 82 NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2022–2027 (USD MILLION)
     10.2 FOOD
               TABLE 83 FOOD: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2017–2021 (USD MILLION)
               TABLE 84 FOOD: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2027 (USD MILLION)
             10.2.1 SNACKS
                       10.2.1.1 Inclination toward protein-rich foods
             10.2.2 CONFECTIONERY
                       10.2.2.1 Nutraceutical ingredients enhance texture, stability, and flavor
             10.2.3 BAKERY
                       10.2.3.1 Adding omega-3 fatty acids lowers baking defects
             10.2.4 DAIRY
                       10.2.4.1 Rising consumer awareness of health advantages of dairy products
             10.2.5 MEAT & MEAT PRODUCTS
                       10.2.5.1 Major source of protein
             10.2.6 BABY FOOD
                       10.2.6.1 High standards of living and preference for convenience foods
                                   TABLE 85 RECOMMENDED DIETARY REFERENCE INTAKES (DRIS) FOR MACRONUTRIENTS
                                   TABLE 86 RECOMMENDED DIETARY REFERENCE INTAKES (DRIS) FOR MICRONUTRIENTS
             10.2.7 OTHERS
                       FIGURE 43 GLOBALLY RISING IMPORTS AND EXPORTS OF CEREALS AND CEREAL PRODUCTS, 2016–2020
                       TABLE 87 FOOD: NUTRACEUTICAL INGREDIENTS MARKET, BY SUB-APPLICATION, 2017–2021 (USD MILLION)
                       TABLE 88 FOOD: NUTRACEUTICAL INGREDIENTS MARKET, BY SUB-APPLICATION, 2022–2027 (USD MILLION)
     10.3 BEVERAGES
               TABLE 89 BEVERAGES: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2017–2021 (USD MILLION)
               TABLE 90 BEVERAGES: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2027 (USD MILLION)
             10.3.1 ENERGY DRINKS
                       10.3.1.1 Offer specific medical and health benefits
             10.3.2 JUICES
                       10.3.2.1 Functional benefits and growing health concerns
             10.3.3 HEALTH DRINKS
                       10.3.3.1 Improves quality by reducing health risks
                                   TABLE 91 NUTRACEUTICAL INGREDIENTS MARKET FOR BEVERAGES, BY SUB-APPLICATION, 2017–2021 (USD MILLION)
                                   TABLE 92 NUTRACEUTICAL INGREDIENTS MARKET FOR BEVERAGES, BY SUB-APPLICATION, 2022–2027 (USD MILLION)
     10.4 PERSONAL CARE
             10.4.1 PREFERENCE FOR ORGANIC PERSONAL CARE PRODUCTS.
                       TABLE 93 PERSONAL CARE: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2017–2021 (USD MILLION)
                       TABLE 94 PERSONAL CARE: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2027 (USD MILLION)
     10.5 ANIMAL NUTRITION
             10.5.1 RISING ANIMAL HEALTH AND NUTRITION MARKET
                       TABLE 95 ANIMAL NUTRITION: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2017–2021 (USD MILLION)
                       TABLE 96 ANIMAL NUTRITION: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2027 (USD MILLION)
     10.6 DIETARY SUPPLEMENTS
             10.6.1 OFFER SEVERAL HEALTH BENEFITS
                       TABLE 97 DIETARY SUPPLEMENTS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2017–2021 (USD MILLION)
                       TABLE 98 DIETARY SUPPLEMENTS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2027 (USD MILLION)

11 NUTRACEUTICAL INGREDIENTS MARKET, BY REGION (Page No. - 178)
     11.1 INTRODUCTION
               TABLE 99 NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2017–2021 (USD MILLION)
               TABLE 100 NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2027 (USD MILLION)
               FIGURE 44 REGIONAL SNAPSHOT: US ACQUIRED LARGEST SHARE IN NUTRACEUTICAL INGREDIENTS MARKET, 2021
     11.2 NORTH AMERICA
               TABLE 101 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2017–2021 (USD MILLION)
               TABLE 102 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2022–2027 (USD MILLION)
               TABLE 103 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017–2021 (USD MILLION)
               TABLE 104 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2022–2027 (USD MILLION)
               TABLE 105 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2017–2021 (USD MILLION)
               TABLE 106 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2022–2027 (USD MILLION)
               TABLE 107 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY FORM, 2017–2021 (USD MILLION)
               TABLE 108 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY FORM, 2022–2027 (USD MILLION)
             11.2.1 US
                       11.2.1.1 Improved quality of livestock-based products amid increased consumer demand
                                   TABLE 109 US: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017–2021 (USD MILLION)
                                   TABLE 110 US: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2022–2027 (USD MILLION)
             11.2.2 CANADA
                       11.2.2.1 Increased government support for R&D
                                   FIGURE 45 CANADA: OVERWEIGHT OR OBESE, BY AGE GROUP AND SEX, 2018
                                   TABLE 111 CANADA: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017–2021 (USD MILLION)
                                   TABLE 112 CANADA: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2022–2027 (USD MILLION)
             11.2.3 MEXICO
                       11.2.3.1 Growing health and wellness trends
                                   FIGURE 46 MEXICO: PER CAPITA EXPENDITURE ON FOOD, 2010–2018
                                   TABLE 113 MEXICO: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017–2021 (USD MILLION)
                                   TABLE 114 MEXICO: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2022–2027 (USD MILLION)
     11.3 EUROPE
               TABLE 115 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2017–2021 (USD MILLION)
               TABLE 116 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2022–2027 (USD MILLION)
               TABLE 117 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017–2021 (USD MILLION)
               TABLE 118 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2022–2027 (USD MILLION)
               TABLE 119 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2017–2021 (USD MILLION)
               TABLE 120 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2022–2027 (USD MILLION)
               TABLE 121 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY FORM, 2017–2021 (USD MILLION)
               TABLE 122 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY FORM, 2022–2027 (USD MILLION)
             11.3.1 GERMANY
                       11.3.1.1 Multiple applications of nutraceuticals in food & beverages and personal care products.
                                   TABLE 123 GERMANY: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017–2021 (USD MILLION)
                                   TABLE 124 GERMANY: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2022–2027 (USD MILLION)
             11.3.2 FRANCE
                       11.3.2.1 Increased health awareness and strategic government initiatives
                                   TABLE 125 FRANCE: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017–2021 (USD MILLION)
                                   TABLE 126 FRANCE: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2022–2027 (USD MILLION)
             11.3.3 UK
                       11.3.3.1 High demand for nutraceutical ingredients from food & beverage industry
                                   TABLE 127 UK: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017–2021 (USD MILLION)
                                   TABLE 128 UK: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2022–2027 (USD MILLION)
             11.3.4 ITALY
                       11.3.4.1 Increased consumption of food supplements
                                   TABLE 129 ITALY: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017–2021 (USD MILLION)
                                   TABLE 130 ITALY: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2022–2027 (USD MILLION)
             11.3.5 SPAIN
                       11.3.5.1 Preference for functional food and beverages
                                   TABLE 131 SPAIN: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017–2021 (USD MILLION)
                                   TABLE 132 SPAIN: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2022–2027 (USD MILLION)
             11.3.6 RUSSIA
                       11.3.6.1 Complicated and expensive registration process
                                   TABLE 133 RUSSIA: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017–2021 (USD MILLION)
                                   TABLE 134 RUSSIA: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2022–2027 (USD MILLION)
             11.3.7 REST OF EUROPE
                       TABLE 135 REST OF EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017–2021 (USD MILLION)
                       TABLE 136 REST OF EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2022–2027 (USD MILLION)
     11.4 ASIA PACIFIC
               FIGURE 47 ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, 2021
               TABLE 137 ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2017–2021 (USD MILLION)
               TABLE 138 ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2022–2027 (USD MILLION)
               TABLE 139 ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017–2021 (USD MILLION)
               TABLE 140 ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2022–2027 (USD MILLION)
               TABLE 141 ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2017–2021 (USD MILLION)
               TABLE 142 ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2022–2027 (USD MILLION)
               TABLE 143 ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY FORM, 2017–2021 (USD MILLION)
               TABLE 144 ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY FORM, 2022–2027 (USD MILLION)
             11.4.1 CHINA
                       11.4.1.1 Changing lifestyles of consumers
                                   TABLE 145 CHINA: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017–2021 (USD MILLION)
                                   TABLE 146 CHINA: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2022–2027 (USD MILLION)
             11.4.2 JAPAN
                       11.4.2.1 Preference for fortified foods over conventional ones
                                   TABLE 147 JAPAN: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017–2021 (USD MILLION)
                                   TABLE 148 JAPAN: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2022–2027 (USD MILLION)
             11.4.3 INDIA
                       11.4.3.1 High consumer demand due to rising hospitalization costs
                                   TABLE 149 INDIA: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017–2021 (USD MILLION)
                                   TABLE 150 INDIA: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2022–2027 (USD MILLION)
             11.4.4 AUSTRALIA & NEW ZEALAND
                       11.4.4.1 Preference for low-calorie foods to prevent chronic conditions
                                   TABLE 151 AUSTRALIA & NEW ZEALAND: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017–2021 (USD MILLION)
                                   TABLE 152 AUSTRALIA & NEW ZEALAND: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2022–2027 (USD MILLION)
             11.4.5 REST OF ASIA PACIFIC
                       TABLE 153 REST OF ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017–2021 (USD MILLION)
                       TABLE 154 REST OF ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2022–2027 (USD MILLION)
     11.5 SOUTH AMERICA
               TABLE 155 SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2017–2021 (USD MILLION)
               TABLE 156 SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2022–2027 (USD MILLION)
               TABLE 157 SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017–2021 (USD MILLION)
               TABLE 158 SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2022–2027 (USD MILLION)
               TABLE 159 SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2017–2021 (USD MILLION)
               TABLE 160 SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2022–2027 (USD MILLION)
               TABLE 161 SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY FORM, 2017–2021 (USD MILLION)
               TABLE 162 SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY FORM, 2022–2027 (USD MILLION)
             11.5.1 BRAZIL
                       11.5.1.1 Rising health consciousness and rapid urbanization
                                   TABLE 163 BRAZIL: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017–2021 (USD MILLION)
                                   TABLE 164 BRAZIL: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2022–2027 (USD MILLION)
             11.5.2 ARGENTINA
                       11.5.2.1 Affinity toward healthy foods and functional beverages
                                   FIGURE 48 PREVALENCE OF UNDERNOURISHMENT IN ARGENTINA, 2012–2019
                                   TABLE 165 ARGENTINA: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017–2021 (USD MILLION)
                                   TABLE 166 ARGENTINA: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2022–2027 (USD MILLION)
             11.5.3 REST OF SOUTH AMERICA
                       TABLE 167 REST OF SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017–2021 (USD MILLION)
                       TABLE 168 REST OF SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2022–2027 (USD MILLION)
     11.6 REST OF THE WORLD (ROW)
               TABLE 169 REST OF THE WORLD: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2017–2021 (USD MILLION)
               TABLE 170 REST OF THE WORLD: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2027 (USD MILLION)
               TABLE 171 REST OF THE WORLD: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017–2021 (USD MILLION)
               TABLE 172 REST OF THE WORLD: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2022–2027 (USD MILLION)
               TABLE 173 REST OF THE WORLD: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2017–2021 (USD MILLION)
               TABLE 174 REST OF THE WORLD: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2022–2027 (USD MILLION)
               TABLE 175 REST OF THE WORLD: NUTRACEUTICAL INGREDIENTS MARKET, BY FORM, 2017–2021 (USD MILLION)
               TABLE 176 REST OF THE WORLD: NUTRACEUTICAL INGREDIENTS MARKET, BY FORM, 2022–2027 (USD MILLION)
             11.6.1 MIDDLE EAST
                       11.6.1.1 Increased demand for healthy foods amid rising health concerns
                                   TABLE 177 MIDDLE EAST: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017–2021 (USD MILLION)
                                   TABLE 178 MIDDLE EAST: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2022–2027 (USD MILLION)
             11.6.2 AFRICA
                       11.6.2.1 Government initiatives for fortification of food with essential vitamins and minerals
                                   TABLE 179 AFRICA: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017–2021 (USD MILLION)
                                   TABLE 180 AFRICA: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2022–2027 (USD MILLION)

12 COMPETITIVE LANDSCAPE (Page No. - 237)
     12.1 OVERVIEW
     12.2 MARKET SHARE ANALYSIS, 2021
               TABLE 181 NUTRACEUTICAL INGREDIENTS MARKET: DEGREE OF COMPETITION (COMPETITIVE)
     12.3 SEGMENTAL REVENUE ANALYSIS OF KEY PLAYERS
               FIGURE 49 SEGMENTAL REVENUE ANALYSIS OF KEY MARKET PLAYERS, 2017–2021 (USD MILLION)
     12.4 STRATEGIES ADOPTED BY KEY PLAYERS
     12.5 COMPANY EVALUATION QUADRANT (KEY PLAYERS)
             12.5.1 STARS
             12.5.2 EMERGING LEADERS
             12.5.3 PERVASIVE PLAYERS
             12.5.4 PARTICIPANTS
                       FIGURE 50 NUTRACEUTICAL INGREDIENTS MARKET: COMPANY EVALUATION QUADRANT, 2021 (KEY PLAYERS)
             12.5.5 PRODUCT FOOTPRINT
                       TABLE 182 COMPANY FOOTPRINT, BY TYPE
                       TABLE 183 COMPANY FOOTPRINT, BY APPLICATION
                       TABLE 184 COMPANY FOOTPRINT, BY REGION
                       TABLE 185 OVERALL COMPANY FOOTPRINT
     12.6 NUTRACEUTICAL INGREDIENTS MARKET: EVALUATION QUADRANT FOR START-UPS/SMES, 2021
             12.6.1 PROGRESSIVE COMPANIES
             12.6.2 STARTING BLOCKS
             12.6.3 RESPONSIVE COMPANIES
             12.6.4 DYNAMIC COMPANIES
                       FIGURE 51 NUTRACEUTICAL INGREDIENTS MARKET: COMPANY EVALUATION QUADRANT, 2021 (START-UPS/SME)
             12.6.5 COMPETITIVE BENCHMARKING OF KEY START-UPS/SMES
                       TABLE 186 NUTRACEUTICAL INGREDIENTS MARKET: DETAILED LIST OF KEY START-UPS/SMES
                       TABLE 187 NUTRACEUTICAL INGREDIENTS MARKET: COMPETITIVE BENCHMARKING OF KEY START-UPS/SMES
     12.7 PRODUCT LAUNCHES, DEALS, AND OTHER DEVELOPMENTS
             12.7.1 PRODUCT LAUNCHES
                       TABLE 188 NUTRACEUTICAL INGREDIENTS: PRODUCT LAUNCHES, 2018–2022
             12.7.2 DEALS
                       TABLE 189 NUTRACEUTICAL INGREDIENTS: DEALS, 2018–2022
             12.7.3 OTHERS
                       TABLE 190 NUTRACEUTICAL INGREDIENTS: OTHERS, 2019-2022

13 COMPANY PROFILES (Page No. - 274)
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
     13.1 INTRODUCTION
     13.2 KEY PLAYERS
             13.2.1 ASSOCIATED BRITISH FOODS PLC
                       TABLE 191 ASSOCIATED BRITISH FOODS PLC: BUSINESS OVERVIEW
                       FIGURE 52 ASSOCIATED BRITISH FOODS PLC: COMPANY SNAPSHOT
                       TABLE 192 ASSOCIATED BRITISH FOODS PLC: PRODUCTS OFFERED
             13.2.2 ARLA FOODS AMBA
                       TABLE 193 ARLA FOODS AMBA: BUSINESS OVERVIEW
                       FIGURE 53 ARLA FOODS AMBA: COMPANY SNAPSHOT
                       TABLE 194 ARLA FOODS AMBA: PRODUCTS OFFERED
             13.2.3 DSM
                       TABLE 195 DSM: BUSINESS OVERVIEW
                       FIGURE 54 DSM: COMPANY SNAPSHOT
                       TABLE 196 DSM: PRODUCTS OFFERED
                       TABLE 197 DSM: DEALS
             13.2.4 INGREDION
                       TABLE 198 INGREDION: BUSINESS OVERVIEW
                       FIGURE 55 INGREDION: COMPANY SNAPSHOT
                       TABLE 199 INGREDION: PRODUCTS OFFERED
                       TABLE 200 INGREDION: PRODUCT LAUNCHES
                       TABLE 201 INGREDION: DEALS
                       TABLE 202 INGREDION: OTHERS
             13.2.5 TATE & LYLE
                       TABLE 203 TATE & LYLE: BUSINESS OVERVIEW
                       FIGURE 56 TATE & LYLE: COMPANY SNAPSHOT
                       TABLE 204 TATE & LYLE: PRODUCTS OFFERED
                       TABLE 205 TATE & LYLE: PRODUCT LAUNCHES
                       TABLE 206 TATE & LYLE: DEALS
                       TABLE 207 TATE & LYLE: OTHERS
             13.2.6 AJINOMOTO CO., INC.
                       TABLE 208 AJINOMOTO CO., INC.: BUSINESS OVERVIEW
                       FIGURE 57 AJINOMOTO CO., INC.: COMPANY SNAPSHOT
                       TABLE 209 AJINOMOTO CO., INC.: PRODUCTS OFFERED
                       TABLE 210 AJINOMOTO CO., INC.: DEALS
                       TABLE 211 AJINOMOTO CO., INC.: OTHERS
             13.2.7 CHR HANSEN HOLDING A/S.
                       TABLE 212 CHR HANSEN HOLDING A/S. BUSINESS OVERVIEW
                       FIGURE 58 CHR HANSEN HOLDING A/S. COMPANY SNAPSHOT
                       TABLE 213 CHR HANSEN HOLDING A/S. PRODUCTS OFFERED
                       TABLE 214 CHR HANSEN HOLDING A/S. PRODUCT LAUNCHES
                       TABLE 215 CHR HANSEN HOLDING A/S. DEALS
                       TABLE 216 CHR HANSEN HOLDING A/S: OTHERS
             13.2.8 KYOWA HAKKO BIO CO., LTD.
                       TABLE 217 KYOWA HAKKO BIO CO., LTD.: BUSINESS OVERVIEW
                       FIGURE 59 KYOWA HAKKO BIO CO., LTD.: COMPANY SNAPSHOT
                       TABLE 218 KYOWA HAKKO BIO CO., LTD.: PRODUCTS OFFERED
             13.2.9 GLANBIA PLC
                       TABLE 219 GLANBIA PLC: BUSINESS OVERVIEW
                       FIGURE 60 GLANBIA PLC: COMPANY SNAPSHOT
                       TABLE 220 GLANBIA PLC: PRODUCTS OFFERED
                       TABLE 221 GLANBIA PLC: PRODUCT LAUNCHES
                       TABLE 222 GLANBIA PLC: DEALS
                       TABLE 223 GLANBIA PLC: OTHERS
             13.2.10 FONTERRA CO-OPERATIVE GROUP LIMITED
                       TABLE 224 FONTERRA CO.-OPERATIVE GROUP LIMITED: BUSINESS OVERVIEW
                       FIGURE 61 FONTERRA CO.-OPERATIVE GROUP LIMITED: COMPANY SNAPSHOT
                       TABLE 225 FONTERRA CO. OPERATIVE GROUP LIMITED: PRODUCTS OFFERED
                       TABLE 226 FONTERRA CO.-OPERATIVE GROUP LIMITED: DEALS
             13.2.11 CARGILL INCORPORATED
                       TABLE 227 CARGILL INCORPORATED: BUSINESS OVERVIEW
                       FIGURE 62 CARGILL INCORPORATED: COMPANY SNAPSHOT
                       TABLE 228 CARGILL INCORPORATED: PRODUCTS OFFERED
                       TABLE 229 CARGILL INCORPORATED: PRODUCT LAUNCHES
                       TABLE 230 CARGILL INCORPORATED: DEALS
                       TABLE 231 CARGILL INCORPORATED: OTHERS
             13.2.12 ADM
                       TABLE 232 ADM: BUSINESS OVERVIEW
                       FIGURE 63 ADM: COMPANY SNAPSHOT
                       TABLE 233 ADM: PRODUCTS OFFERED
                       TABLE 234 ADM: PRODUCT LAUNCHES
                       TABLE 235 ADM: DEALS
                       TABLE 236 ADM: OTHERS
             13.2.13 INTERNATIONAL FLAVORS & FRAGRANCES INC.
                       TABLE 237 INTERNATIONAL FLAVORS & FRAGRANCES INC.: BUSINESS OVERVIEW
                       FIGURE 64 INTERNATIONAL FLAVORS & FRAGRANCES INC.: COMPANY SNAPSHOT
                       TABLE 238 INTERNATIONAL FLAVORS & FRAGRANCES INC.: PRODUCTS OFFERED
                       TABLE 239 INTERNATIONAL FLAVORS & FRAGRANCES INC.: PRODUCT LAUNCHES
                       TABLE 240 INTERNATIONAL FLAVORS & FRAGRANCES INC.: DEALS
                       TABLE 241 INTERNATIONAL FLAVORS & FRAGRANCES INC.: OTHERS
             13.2.14 BASF SE
                       TABLE 242 BASF SE: BUSINESS OVERVIEW
                       FIGURE 65 BASF SE: COMPANY SNAPSHOT
                       TABLE 243 BASF SE: PRODUCTS OFFERED
                       TABLE 244 BASF SE: OTHERS
             13.2.15 KERRY GROUP PLC
                       TABLE 245 KERRY GROUP PLC: BUSINESS OVERVIEW
                       FIGURE 66 KERRY GROUP PLC: COMPANY SNAPSHOT
                       TABLE 246 KERRY GROUP PLC: PRODUCTS OFFERED
                       TABLE 247 KERRY GROUP PLC: PRODUCT LAUNCHES
                       TABLE 248 KERRY GROUP PLC: DEALS
                       TABLE 249 KERRY GROUP PLC: OTHERS
     13.3 OTHER PLAYERS
             13.3.1 BALCHEM INC.
             13.3.2 SYDLER INDIA PVT. LTD.
             13.3.3 PROBI
             13.3.4 DIVI’S LABORATORIES LIMITED
             13.3.5 MARTIN BAUER
             13.3.6 BENEO GMBH
             13.3.7 NEXIRA
             13.3.8 ROQUETTE FRÈRES
             13.3.9 CONAGEN, INC.
             13.3.10 NUTRACEUTICALS GROUPS

*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.

14 ADJACENT & RELATED MARKETS (Page No. - 348)
     14.1 INTRODUCTION
     14.2 LIMITATIONS
     14.3 FUNCTIONAL FOOD INGREDIENTS MARKET
             14.3.1 MARKET DEFINITION
             14.3.2 MARKET OVERVIEW
             14.3.3 FUNCTIONAL FOOD INGREDIENTS MARKET, BY TYPE
                       14.3.3.1 Introduction
                                   TABLE 250 FUNCTIONAL FOOD INGREDIENTS MARKET, BY TYPE, 2016–2020 (USD MILLION)
                                   TABLE 251 FUNCTIONAL FOOD INGREDIENTS MARKET, BY TYPE, 2021–2026 (USD MILLION)
             14.3.4 FUNCTIONAL FOOD INGREDIENTS MARKET, BY REGION
                       14.3.4.1 Introduction
                                   TABLE 252 FUNCTIONAL FOOD INGREDIENTS MARKET, BY REGION, 2016–2020 (USD MILLION)
                                   TABLE 253 FUNCTIONAL FOOD INGREDIENTS MARKET, BY REGION, 2021–2026 (USD MILLION)
     14.4 NUTRACEUTICAL EXCIPIENTS MARKET
             14.4.1 MARKET DEFINITION
             14.4.2 MARKET OVERVIEW
             14.4.3 NUTRACEUTICAL EXCIPIENTS MARKET, BY END PRODUCT
                       14.4.3.1 Introduction
                                   TABLE 254 NUTRACEUTICAL EXCIPIENTS MARKET, BY END PRODUCT, 2018–2025 (USD MILLION)
                                   TABLE 255 NUTRACEUTICAL EXCIPIENTS MARKET, BY END PRODUCT, 2018–2025 (KT)
             14.4.4 NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION
                       14.4.4.1 Introduction
                                   TABLE 256 NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2018–2025 (USD MILLION)
                                   TABLE 257 NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2018–2025 (KT)

15 APPENDIX (Page No. - 356)
     15.1 DISCUSSION GUIDE
     15.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
     15.3 CUSTOMIZATION OPTIONS
     15.4 RELATED REPORTS
     15.5 AUTHOR DETAILS